Tiziana Life Sciences (TILS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TILS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Tiziana Life Sciences Shares Up After Expanding Multiple Sclerosis TrialJune 13 at 11:51 PM | marketwatch.comTiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement ...June 13 at 11:26 AM | gurufocus.comTiziana Life Sciences Expands Phase 2 MS Trial with New SiteJune 13 at 11:26 AM | tipranks.comShares of Tiziana Life Sciences (TLSA) Climb on CEO's Upcoming PresentationJune 13 at 10:19 AM | gurufocus.comTiziana Life Sciences to Present Intranasal Foralumab Findings at Bio International ConventionJune 13 at 9:00 AM | tipranks.comTiziana Life Sciences Showcases Breakthrough in Alzheimer’s Treatment with Intranasal ForalumabMay 23, 2025 | tipranks.comTiziana Life Sciences’ Nasal Foralumab Shows Promise in Alzheimer’s TreatmentMay 15, 2025 | tipranks.comExecutive Chairman Increases Stake in Tiziana Life Sciences (TLSA) | TLSA Stock NewsMay 12, 2025 | gurufocus.comTiziana Life Sciences Chairman Increases Stake with Recent Share PurchaseMay 12, 2025 | tipranks.comTiziana Life Sciences Reports Promising Alzheimer’s Treatment ResultsMay 9, 2025 | tipranks.comDosing begins in Tiziana Life Sciences’ trial of foralumab for na-SPMSApril 24, 2025 | msn.comTiziana Life Sciences (TLSA) Expands Clinical Trial for MS Treatment | TLSA Stock NewsApril 23, 2025 | gurufocus.comTiziana Life Sciences Expands Phase 2 Trial for Intranasal Foralumab with UMass DosingApril 23, 2025 | tipranks.comTiziana Life Sciences Expands Phase 2 Trial for Multiple Sclerosis TreatmentApril 2, 2025 | tipranks.comTiziana Life Sciences files $250M mixed securities shelfMarch 27, 2025 | markets.businessinsider.comTiziana Life Sciences begins dosing in trial of therapy for multiple sclerosisMarch 27, 2025 | msn.comTiziana Life Sciences announces dosing of new patients at Yale MS CenterMarch 26, 2025 | markets.businessinsider.comTiziana Life Sciences CEO to Present at ROTH ConferenceMarch 17, 2025 | tipranks.comTiziana Life Sciences regains compliance with Nasdaq listing ruleMarch 14, 2025 | markets.businessinsider.comTiziana Life Sciences Regains Nasdaq Compliance, Secures Continued ListingMarch 14, 2025 | tipranks.comTiziana Life Sciences regains Nasdaq complianceMarch 14, 2025 | seekingalpha.comTiziana Life Sciences files IND application with FDA for ALS Phase 2 trialMarch 4, 2025 | markets.businessinsider.comTiziana Life Sciences ticks up on IND submission for mid-stage trial of its ALS treatmentMarch 4, 2025 | msn.comTiziana Life Sciences Advances ALS Treatment with FDA IND SubmissionMarch 4, 2025 | tipranks.comTiziana Life Sciences’ nasal therapy shows efficacy in traumatic brain injuryFebruary 27, 2025 | markets.businessinsider.comTiziana stock jumps 12% on TBI drug study publicationFebruary 27, 2025 | msn.comTiziana Life Sciences Unveils Promising Nasal Therapy for Traumatic Brain InjuryFebruary 27, 2025 | tipranks.comTiziana Life Sciences Nears Completion of Promising Long COVID Treatment StudyFebruary 25, 2025 | tipranks.comTiziana enters product development services agreement with RenaissanceFebruary 21, 2025 | markets.businessinsider.comTiziana Life Sciences Partners with Renaissance for Nasal Drug Scale-UpFebruary 21, 2025 | tipranks.comTiziana Life Sciences enters product development services pact with Renaissance LakewoodFebruary 21, 2025 | seekingalpha.comTiziana Life Sciences Expands Access to Multiple Sclerosis TreatmentFebruary 18, 2025 | tipranks.comTiziana Life Sciences Highlights Foralumab’s Potential in Alzheimer’s TreatmentFebruary 11, 2025 | tipranks.comTiziana Life Sciences Faces Nasdaq Compliance ChallengeJanuary 31, 2025 | tipranks.comTiziana Life Sciences Reports Breakthrough in Spinal Cord Injury TreatmentJanuary 24, 2025 | tipranks.comTiziana Life Sciences Shares Higher on Positive Results for Spinal Cord Injury TreatmentJanuary 23, 2025 | marketwatch.comTiziana reports progress in spinal cord injury treatmentJanuary 23, 2025 | msn.comNeurology-Focused Tiziana Life Confirms Discovery In Multiple Sclerosis Therapy StudyJanuary 23, 2025 | benzinga.comTiziana Life Sciences announces discovery of new immune biomarkersJanuary 23, 2025 | markets.businessinsider.comTiziana’s Nasal Therapy Reduces GLP-1 Side EffectsJanuary 10, 2025 | tipranks.comTiziana Life Sciences announces review article on foralumab’s potentialJanuary 9, 2025 | markets.businessinsider.comTiziana Life Sciences’ Foralumab Shows Promise in Neurodegenerative Disease TreatmentJanuary 9, 2025 | markets.businessinsider.comTiziana Life Sciences announces first patient dosed with intranasal foralumabDecember 17, 2024 | tipranks.comTiziana Life Sciences Expands MS Clinical Trial NetworkDecember 5, 2024 | markets.businessinsider.comTiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS AssociationNovember 19, 2024 | markets.businessinsider.comTiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination StudyNovember 1, 2024 | finanznachrichten.deTiziana Life Sciences Plans Share Sale with JefferiesOctober 26, 2024 | markets.businessinsider.comTiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s DiseaseSeptember 20, 2024 | markets.businessinsider.comTiziana Life Appoints Ivor Elrifi As CEOAugust 19, 2024 | markets.businessinsider.comTiziana Life Sciences Appoints Ivor Elrifi as CEOAugust 19, 2024 | marketwatch.com Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Email Address TILS Media Mentions By Week TILS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TILS News Sentiment▼0.380.87▲Average Medical News Sentiment TILS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TILS Articles This Week▼51▲TILS Articles Average Week Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRTC News Today OXB News Today FARN News Today BVXP News Today 4BB News Today AVCT News Today SCLP News Today HVO News Today OBI News Today SBTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:TILS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
